Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

Literature DB >> 29363752

Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

Lucia Y Chen¹, Raakhee Shah¹, Kate Cwynarski¹, Jonathan Lambert¹, Christopher McNamara¹, Sajir G Mohamedbhai¹, Andres Virchis¹, William Townsend¹, Shirley D'Sa¹, Kirit M Ardeshna¹.

Abstract

Entities: Chemical Gene Species

Keywords: infusion-related reaction; lymphoma; monoclonal antibody; ofatumumab; rituximab

Mesh：

Substances：

Year: 2018 PMID： 29363752 DOI： 10.1111/bjh.15110

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

Review 1. Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies.

Authors: Esther Melamed; Michael William Lee
Journal: Front Immunol Date: 2020-01-10 Impact factor: 7.561

2. Successful treatment of hairy cell leukemia variant with obinutuzumab.

Authors: Diana Al-Sarayfi; Freek O Meeuwes; Thijs Oude Munnink; Wouter Plattel; Stefano Rosati; Estella Matutes; Marcel Nijland
Journal: Ann Hematol Date: 2021-06-04 Impact factor: 3.673

2 in total